Increased resistance to mycobacterial infection in the absence of interleukin-10

Immunology

Volumn 100, Issue 4, 2000, Pages 494-501

  Jacobs, M ^a   Brown, N ^a   Allie, N ^a   Gulert, R ^a   Ryffel, B ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; BCG VACCINE; CD11B ANTIGEN; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; GRANULOMA; IMMUNE RESPONSE; INFECTION RESISTANCE; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ANIMALS; CYTOKINES; FEMALE; GRANULOMA; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; INTERLEUKIN-10; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES; TH1 CELLS; TUBERCULIN; TUBERCULOSIS;

EID: 0033854068     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00053.x     Document Type: Article

References (24)

1. 1. Cooper A.M. & Flynn J.L. (1995) The protective immune response to Mycobacterium tuberculosis. Curr Opin Immunol 7, 512.
2. 2. Bloom B.R. (1994) Tuberculosis. In: Tuberculosis, Pathogenesis, Protection and Control (ed. B. R. Bloom), p. 1-43. A.S.M. Press, New York.
3. 3. Mosmann T.R. & Coffman R.L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145.
4. 4. Cooper A.M., Roberts A.D., Rhoades E.R., Callahan J.E., Getzy D.M. & Orme I.M. (1995) The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84, 423.
5. 5. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G. & Orme I.M. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178, 2243.
6. 6. Cooper A.M., Magram J., Ferrante J. & Orme I.M. (1997) Interleukin 12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186, 39.
7. 7. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J. & Bloom B.R. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561.
8. 8. Kamijo R., Le J., Shapiro D. et al. (1993) Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 178, 1435.
9. 9. Altare F., Durandy A., Lammas D. et al. (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280, 1432.
10. 10. De Jong R., Altare F., Haagen I.A. et al. (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435.
11. 11. Kindler V., Sappino A.-P., Grau G.E., Piguet P.-F. & Vassalli P. (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731.
12. 12. Senaldi G., Yin S., Shaklee C.L., Piguet P.-F., Mak T.W. & Ulich T.R. (1996) Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor 1 (TNF-RI) knockout mice and by treatment with soluble TNF-R1. J Immunol 157, 5022.
13. 13. Bermudez L.E. & Champsi J. (1993) Infection with Mycobacterium avium induces production of interleukin-10, and administration of anti IL-10 antibody is associated with enhanced resistance in mice. Infect Immun 16, 3093.
14. 14. Bogdan C. & Nathan C. (1993) Modulation of macrophage function by transforming growth factor beta, interleukin-10. Ann N Y Acad Sci 685, 713.
15. 15. Murray P.J., Wang L., Onufryk C., Tepper R.I. & Young R.A. (1997) T cell-derived IL-10 antagonizes macrophage function mycobacterial infecton. J Immunol 158, 315.
16. 16. Denis M. & Ghadirian E. (1993) IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 151, 5425.
17. 17. Erb K.J., Kirman J., Delahunt B., Chen W. & Le Gros G. (1998) IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunol Cell Biol 76, 41.
18. 18. North R.J. (1998) Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113, 55.
19. 19. Murray P.J. & Young A.Y. (1999) Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67, 3087.
20. 20. Kuhn R., Lohler J., Rennick D., Rajewsky K. & Muller W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263.
21. 21. Ryffel B., Car B.D., Gunn H., Roman D. & Mihatsch M.J. (1994) Interleukin-6 exacerbates glomerulonephritis in (NZB × NZW) F1 mice. Am J Pathol 144, 927.
22. 22. Lucas R., Tacchini-Cottier F., Guler R. et al. (1999) A role for lymphotoxin beta receptor in host defence against Mycobacterium bovis BCG infection. Eur J Immunol 29, 4002.
23. 23. Yang X., Gartner J., Zhu L., Wang S. & Brunham R.C. (1999) IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granulomaa formation following Chlamydia trachomatis lung infection. J Immunol 162, 1010.
24. 24. Groux H., Cottrez F., Rouleau M., Roncarolo M.G. & Coffman R.L. (1998) A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol 162, 1723.